AU8972901A - Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof - Google Patents

Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof

Info

Publication number
AU8972901A
AU8972901A AU8972901A AU8972901A AU8972901A AU 8972901 A AU8972901 A AU 8972901A AU 8972901 A AU8972901 A AU 8972901A AU 8972901 A AU8972901 A AU 8972901A AU 8972901 A AU8972901 A AU 8972901A
Authority
AU
Australia
Prior art keywords
perfluoroalkyl
producing
same
sugar residues
containing complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8972901A
Inventor
Johannes Dr Platzek
Peter Mareski
Ulrich Niedballa
Bernd Dr Raduchel
Hanns-Joachim Weinmann
Bernd Misselwitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU8972901A publication Critical patent/AU8972901A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU8972901A 2000-08-11 2001-07-23 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof Pending AU8972901A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040381A DE10040381C1 (en) 2000-08-11 2000-08-11 Perfluoroalkyl-containing complexes with sugar residues, process for their preparation and their use
PCT/EP2001/008499 WO2002014309A1 (en) 2000-08-11 2001-07-23 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof

Publications (1)

Publication Number Publication Date
AU8972901A true AU8972901A (en) 2002-02-25

Family

ID=7652861

Family Applications (2)

Application Number Title Priority Date Filing Date
AU8972901A Pending AU8972901A (en) 2000-08-11 2001-07-23 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof
AU2001289729A Ceased AU2001289729B2 (en) 2000-08-11 2001-07-23 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001289729A Ceased AU2001289729B2 (en) 2000-08-11 2001-07-23 Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof

Country Status (31)

Country Link
EP (1) EP1307446B1 (en)
JP (1) JP2004506631A (en)
KR (1) KR100820387B1 (en)
CN (1) CN1249058C (en)
AR (1) AR035579A1 (en)
AT (1) ATE293623T1 (en)
AU (2) AU8972901A (en)
BG (1) BG107540A (en)
BR (1) BR0113192A (en)
CA (1) CA2418790A1 (en)
CZ (1) CZ2003340A3 (en)
DE (2) DE10040381C1 (en)
DK (1) DK1307446T3 (en)
EE (1) EE200300059A (en)
ES (1) ES2240517T3 (en)
HK (1) HK1062016A1 (en)
HR (1) HRP20030172A2 (en)
HU (1) HUP0300744A3 (en)
IL (1) IL154328A0 (en)
MX (1) MXPA03001285A (en)
NO (1) NO20030648L (en)
NZ (1) NZ524079A (en)
PL (1) PL360359A1 (en)
PT (1) PT1307446E (en)
RU (1) RU2280644C2 (en)
SK (1) SK1542003A3 (en)
TW (1) TWI243170B (en)
UA (1) UA75364C2 (en)
WO (1) WO2002014309A1 (en)
YU (1) YU10403A (en)
ZA (1) ZA200301948B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19948651B4 (en) * 1999-09-29 2006-10-05 Schering Ag Galenic formulations containing para and diamagnetic perfluorinated compounds, their preparation and use
DE10231799B4 (en) * 2002-07-10 2006-10-05 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast agents in MR imaging for the presentation of intravascular thrombi
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
DE10260372B4 (en) 2002-12-13 2007-01-04 Schering Ag Magnetic resonance imaging apparatus and method for spatially resolved imaging
WO2007009637A2 (en) * 2005-07-15 2007-01-25 Bayer Schering Pharma Aktiengesellschaft Complexes containing perfluoroalkyl, their use as contrast media for nmr, x-ray and radio diagnosis and radiotherapy
DE102006049821A1 (en) * 2006-10-18 2008-04-24 Bayer Schering Pharma Aktiengesellschaft New, well tolerated metal chelates, for use as radiodiagnostic, radiotherapeutic or NMR and X-ray diagnostic agents, contain chelator and perfluorinated polyethylene glycol residues
RU2450832C2 (en) * 2006-10-25 2012-05-20 Конинклейке Филипс Электроникс Н.В. Radiopaque substances for prostate cancer detection
DE102008024976A1 (en) 2008-05-23 2009-12-17 Marvis Technologies Gmbh Medical instrument
JP2011190183A (en) * 2010-03-11 2011-09-29 Noguchi Institute Fluorous sugar-bonded crown ether derivative
EP2450067A1 (en) 2010-10-18 2012-05-09 MaRVis Technologies GmbH Medical device
EP2484388A1 (en) 2011-02-05 2012-08-08 MaRVis Technologies GmbH Implantable or insertable MRI-detectable medical device having a coating comprising paramagnetic ions and a process for preparing it
EP2692365A1 (en) 2012-08-03 2014-02-05 MaRVis Medical GmbH Implantable or insertable MRI-detectable medical device having a coating comprising paramagnetic ions and a process for preparing it
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
CA3044877A1 (en) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
JOP20210114A1 (en) 2018-11-23 2023-01-30 Bayer Ag Formulation of contrast media and process of preparation thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
AU623901B2 (en) * 1988-01-26 1992-05-28 Nycomed As Paramagnetic compounds comprising chelating moiety, linker group macro molecule and paramagnetic metal
SG49726A1 (en) * 1989-10-23 1998-06-15 Nycomed Salutar Inc Compounds
US5330743A (en) * 1992-11-12 1994-07-19 Magnetic Research, Inc. Aminosaccharide contrast agents for magnetic resonance images
IL115670A (en) * 1994-10-21 1999-11-30 Nihon Mediphysics Co Ltd Diagnostic imaging agent
DE19603033A1 (en) * 1996-01-19 1997-07-24 Schering Ag Perfluoroalkyl-containing metal complexes, processes for their preparation and their use in NMR diagnostics
DE19728954C1 (en) * 1997-06-30 1999-04-22 Schering Ag Saccharide conjugates, pharmaceutical compositions containing them, processes for their preparation and their use
DE19729013A1 (en) * 1997-07-03 1999-02-04 Schering Ag Oligomeric, perfluoroalkyl-containing compounds, processes for their preparation and their use in NMR diagnostics
DE19744004C1 (en) * 1997-09-26 1999-07-22 Schering Ag Lipophilic metal complexes for necrosis and infarct imaging
DE19758105A1 (en) * 1997-12-18 1999-06-24 Schering Ag New dendritic polymer-saccharide conjugates
DE19914101C1 (en) * 1999-03-22 2000-10-12 Schering Ag Perfluoroalkylamides, their preparation and their use in diagnostics
DE19948651B4 (en) * 1999-09-29 2006-10-05 Schering Ag Galenic formulations containing para and diamagnetic perfluorinated compounds, their preparation and use

Also Published As

Publication number Publication date
EP1307446B1 (en) 2005-04-20
NO20030648D0 (en) 2003-02-10
DE50105965D1 (en) 2005-05-25
EP1307446A1 (en) 2003-05-07
HUP0300744A3 (en) 2009-01-28
PL360359A1 (en) 2004-09-06
AU2001289729B2 (en) 2006-11-16
YU10403A (en) 2006-05-25
EE200300059A (en) 2004-12-15
WO2002014309A1 (en) 2002-02-21
PT1307446E (en) 2005-08-31
HUP0300744A2 (en) 2003-09-29
DK1307446T3 (en) 2005-08-15
HRP20030172A2 (en) 2005-04-30
IL154328A0 (en) 2003-09-17
SK1542003A3 (en) 2003-10-07
CA2418790A1 (en) 2003-02-07
CZ2003340A3 (en) 2003-09-17
NO20030648L (en) 2003-04-11
ES2240517T3 (en) 2005-10-16
RU2280644C2 (en) 2006-07-27
KR100820387B1 (en) 2008-04-08
TWI243170B (en) 2005-11-11
AR035579A1 (en) 2004-06-16
HK1062016A1 (en) 2004-10-15
UA75364C2 (en) 2006-04-17
ATE293623T1 (en) 2005-05-15
BG107540A (en) 2003-11-28
JP2004506631A (en) 2004-03-04
ZA200301948B (en) 2004-06-25
CN1249058C (en) 2006-04-05
BR0113192A (en) 2003-07-15
KR20030024855A (en) 2003-03-26
MXPA03001285A (en) 2004-05-17
NZ524079A (en) 2005-10-28
DE10040381C1 (en) 2002-06-06
CN1468234A (en) 2004-01-14

Similar Documents

Publication Publication Date Title
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
WO2002015264A3 (en) Encapsulated organic-electronic component, method for producing the same and use thereof
HK1040266A1 (en) Titanium alloy and method for producing the same.
HUP0401293A3 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
IL146105A0 (en) 5-pyridyl-1, 3-azole compounds, process for producing the same and use thereof
EP1216621A4 (en) Soft candies and process for producing the same
MXPA03000574A (en) Glass-ceramics, process for their preparation and use.
AU8972901A (en) Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof
HUP0402385A3 (en) 5-phenylpyrimidines, fungicide compositions comprising the same, method for producing and use thereof
AU2001289729A1 (en) Perfluoroalkyl-containing complexes comprising sugar residues, method for producing the same and use thereof
ZA200300743B (en) DDS compound and process for the preparation thereof.
HUP0401622A3 (en) Gelling sugar and method for producing the same
IL156162A0 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof.
HK1043921A1 (en) Ornamental pad and method for producing the same.
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
EP1273657A4 (en) Novel protein, process for producing the same and use thereof
AU7560200A (en) Fat originating in cupuassu seed, process for producing the same and use thereof
EP1489087A4 (en) Bisphosphine, process for producing the same, and use thereof
HK1036519A1 (en) Voltage-nonlinear resistance and process for producing the same.
EP1374702A4 (en) Flavor materials and process for producing the same
AU2479202A (en) Method for producing microspherical crystallites from linear polysaccharides, corresponding microspherical crystallites and the use thereof
EP1331269A4 (en) Novel protein, process for producing the same and use thereof
EP1295940A4 (en) Polypeptides, use thereof and process for producing the same
EP1338275A4 (en) Pharmaceutical composition, the use thereof and method for producing said composition
AU2001210580A1 (en) High-nicotine tobacco and process for producing the same